These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16843173)

  • 1. Common sense, dollars and cents, and drug-eluting stents.
    Vaitkus PT
    J Am Coll Cardiol; 2006 Jul; 48(2):268-9. PubMed ID: 16843173
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dollars and sense of drug-eluting stents.
    Brophy JM
    CMAJ; 2005 Feb; 172(3):361-2. PubMed ID: 15684119
    [No Abstract]   [Full Text] [Related]  

  • 6. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
    Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevaliers B; DiMario C; Fajadeto J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Berenger M; Boam A; Calle JP; Campo G; Carlier S; de Schepper J; Di Bisceglie G; Dobbels H; Farb A; Ghislain JC; Hellbardt S; ten Hoedt R; Isaia C; de Jong P; Lekehal M; LeNarz L; Mhullain FN; Nagai H; Patteet A; Paunovic D; Potgieter A; Purdy I; Raveau-Landon C; Ternstrom S; Van Wuytswinkel J; Waliszewski M;
    EuroIntervention; 2009 Jan; 4(4):427-36. PubMed ID: 19284063
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic impact of drug-eluting stents on hospital systems: a disease-state model.
    Kong DF; Eisenstein EL; Sketch MH; Zidar JP; Ryan TJ; Harrington RA; Newman MF; Smith PK; Mark DB; Califf RM
    Am Heart J; 2004 Mar; 147(3):449-56. PubMed ID: 14999193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are drug-eluting stents cost-effective? It depends on whom you ask.
    Ryan J; Cohen DJ
    Circulation; 2006 Oct; 114(16):1736-43; discussion 1744. PubMed ID: 17043177
    [No Abstract]   [Full Text] [Related]  

  • 9. "Me-too" products--friend or foe?
    Lee TH
    N Engl J Med; 2004 Jan; 350(3):211-2. PubMed ID: 14724297
    [No Abstract]   [Full Text] [Related]  

  • 10. [Position paper on the use of drug eluting stents (DES) in percutaneous coronary interventions in patients with coronary heart disease].
    Levenson B; ;
    Z Kardiol; 2003 Jul; 92(7):606-12. PubMed ID: 12883846
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-eluting stents: the price is not right.
    Eisenberg MJ
    Circulation; 2006 Oct; 114(16):1745-54; discussion 1754. PubMed ID: 17043178
    [No Abstract]   [Full Text] [Related]  

  • 12. Economics and outcomes of coronary stenting: are stents right for everybody?
    Weintraub WS
    J Invasive Cardiol; 2000 Apr; 12(4):200-2. PubMed ID: 10785673
    [No Abstract]   [Full Text] [Related]  

  • 13. The costs of drug-eluting coronary stents among Medicare beneficiaries.
    Groeneveld PW; Matta MA; Greenhut AP; Yang F
    Am Heart J; 2008 Jun; 155(6):1097-105. PubMed ID: 18513525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of recent US cost estimates of revascularization.
    Nagle PC; Smith AW
    Am J Manag Care; 2004 Oct; 10(11 Suppl):S370-6. PubMed ID: 15603246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting the balance: direct stenting a novel approach to improve the cost effectiveness of intra-coronary stenting.
    Cotton JM; Kearney MT; Wainwright RJ
    Eur Heart J; 2000 Jan; 21(2):170. PubMed ID: 10637091
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary stenting: costly or cost-effective?
    Cohen DJ; Baim DS
    J Invasive Cardiol; 1995; 7 Suppl A():36A-42A. PubMed ID: 10155115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact on physicians and hospitals of proposed changes in Medicare reimbursement for coronary interventions.
    Vaitkus PT
    Am Heart J; 1999 Feb; 137(2):258-63. PubMed ID: 9924159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical economic considerations of coronary stenting.
    Szucs TD
    Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart catheter in stable coronary heart disease. Drugs are equally effective].
    Einecke D
    MMW Fortschr Med; 2007 Apr; 149(15):10, 12. PubMed ID: 17668771
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing subacute thrombosis.
    Pate G; Webb JG
    J Invasive Cardiol; 2002 Jul; 14(7):369-70. PubMed ID: 12082188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.